
Current Price | $0.96 | Mkt Cap | $33.1M |
---|---|---|---|
Open | $0.95 | P/E Ratio | -5.61 |
Prev. Close | $0.95 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.91 - $0.97 | Volume | 2,108 |
52-Wk Range | $0.74 - $1.39 | Avg. Daily Vol. | 11,757 |
A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.
Current Price | $0.96 | Mkt Cap | $33.1M |
---|---|---|---|
Open | $0.95 | P/E Ratio | -5.61 |
Prev. Close | $0.95 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.91 - $0.97 | Volume | 2,108 |
52-Wk Range | $0.74 - $1.39 | Avg. Daily Vol. | 11,757 |
The best Bull and Bear pitches based on recency and number of recommendations.
I have had skin cancer and will have more and am waiting for my dermatologist to buy a non-invasive tester so he doesn't just freeze everything off or in the worse looking ones have me make a separate appointment for removal/biopsy.
Based on MELA's press release, it is unclear if MelaFind will find new cases of melanoma that dermatologists don't already suspect. MELA's study was done in people the dermatologists already suspected melanoma, not the general public. It is not a… More
Read the most recent pitches from players about SSKN.
Recs
Medical technology in the dermatology field. Good revenue/income growth and positive cash flow.
Recs
prediction TOS
Recs
I have had skin cancer and will have more and am waiting for my dermatologist to buy a non-invasive tester so he doesn't just freeze everything off or in the worse looking ones have me make a separate appointment for removal/biopsy.
Find the members with the highest scoring picks in SSKN.
anticitradeshort (27.15) Score: +505.34
The Score Leader is the player with the highest score across all their picks in SSKN.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
anticitradeshort | 27.15 | 4/20/2009 |
![]() |
NS | $327.00 | -99.71% | +405.63% | +505.34 | 0 Comment | |
wackydaddy | 20.82 |
|
![]() |
3Y | $425.00 | -99.78% | +388.46% | +488.24 | 1 Comment | |
ModernDayWarrior | 32.91 | 10/27/2009 |
![]() |
5Y | $564.00 | -99.83% | +299.94% | +399.77 | 0 Comment | |
NobullWalrus | < 20 | 10/27/2009 |
![]() |
1Y | $564.00 | -99.83% | +299.94% | +399.77 | 1 Comment | |
39272x6 | 74.06 | 11/13/2009 |
![]() |
5Y | $415.00 | -99.77% | +291.60% | +391.37 | 0 Comment | |
drugncover | < 20 | 9/10/2010 |
![]() |
1Y | $337.00 | -99.72% | +284.05% | +383.76 | 0 Comment | |
![]() |
markofzorro | 38.44 | 5/19/2010 |
![]() |
5Y | $295.50 | -99.68% | +283.50% | +383.17 | 10 Comments |
jroren | 98.25 | 6/21/2010 |
![]() |
3M | $440.50 | -99.78% | +278.41% | +378.20 | 0 Comment | |
Jaspers0Debt | 62.53 | 11/17/2010 |
![]() |
5Y | $132.50 | -99.28% | +261.48% | +360.75 | 0 Comment | |
fastred55 | 26.44 | 11/23/2010 |
![]() |
5Y | $212.50 | -99.55% | +260.41% | +359.96 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.